Compare AMLX & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMLX | CASH |
|---|---|---|
| Founded | 2014 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2021 | 1996 |
| Metric | AMLX | CASH |
|---|---|---|
| Price | $17.61 | $100.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $20.11 | ★ $96.33 |
| AVG Volume (30 Days) | ★ 1.2M | 172.3K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.20% |
| EPS Growth | ★ 65.46 | 18.88 |
| EPS | N/A | ★ 1.57 |
| Revenue | $380,786,000.00 | ★ $839,894,000.00 |
| Revenue This Year | N/A | $7.56 |
| Revenue Next Year | N/A | $6.02 |
| P/E Ratio | ★ N/A | $63.33 |
| Revenue Growth | ★ 1612.94 | 11.29 |
| 52 Week Low | $4.41 | $65.93 |
| 52 Week High | $18.61 | $101.26 |
| Indicator | AMLX | CASH |
|---|---|---|
| Relative Strength Index (RSI) | 64.35 | 75.91 |
| Support Level | $13.19 | $87.19 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.91 | 2.00 |
| MACD | 0.26 | 0.77 |
| Stochastic Oscillator | 83.26 | 89.79 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.